Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Vascular Surgery

Free Subscription Articles published in Thromb Haemost Retrieve available abstracts of 26 articles: HTML format

Single Articles

August 2023
1. GOROG DA, Jeyalan V, Markides RIL, Navarese EP, et al
   Comparison of De-escalation of DAPT Intensity or Duration in East Asian and Western Patients with ACS Undergoing PCI: A Systematic Review and Meta-analysis.
   Thromb Haemost. 2023;123:773-792.
   PubMed     Abstract available
   
   
   June 2023
2. SONG H, Ahn JH, Kang MG, Kim KH, et al
   Post-PCI Risk Assessment by Inflammation Activity According to Disease Acuity and Time from Procedure.
   Thromb Haemost. 2023;123:627-640.
   PubMed     Abstract available
   
   
   December 2022
3. VERHEUGT FWA, Huber K, Clemmensen P, Collet JP, et al
   Platelet P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention: An Emerging Option for Antiplatelet Therapy De-escalation.
   Thromb Haemost. 2022 Dec 30. doi: 10.1055/s-0042-1755330.
   PubMed     Abstract available
   
   
   November 2022
4. KOCH T, Lahu S, Coughlan JJ, Cassese S, et al
   Association between Platelet Count and Treatment Effect of Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.
   Thromb Haemost. 2022 Nov 28. doi: 10.1055/a-1988-5047.
   PubMed     Abstract available
   
   
   October 2022
5. ROONGSANGMANOON W, Chichareon P, Angkananard T, Suwannasom P, et al
   External validation of ACUITY/HORIZON bleeding risk score among acute coronary syndrome patients in Thai PCI Registry.
   Thromb Haemost. 2022 Oct 20. doi: 10.1055/a-1964-8247.
   PubMed     Abstract available
   
   
   September 2022
6. RIKKEN SAOF, Storey RF, Andreotti F, Clemmensen P, et al
   Parenteral Antiplatelet Drugs in ST-Elevation Myocardial Infarction: Current Status and Future Directions.
   Thromb Haemost. 2022 Sep 8. doi: 10.1055/s-0042-1753479.
   PubMed     Abstract available
   
   
   May 2022
7. ZHANG Y, Zhang Y, Shi X, Lin B, et al
   Clopidogrel versus Ticagrelor in CYP2C19 Loss-of-Function Allele Noncarriers: A Real-World Study in China.
   Thromb Haemost. 2022;122:842-852.
   PubMed     Abstract available
   
   
   April 2022
8. PATTI G, Grisafi L, Spinoni E, Rognoni A, et al
   Safety and efficacy of selective, clopidogrel-based strategies in acute coronary syndrome: a study-level meta-analysis.
   Thromb Haemost. 2022 Apr 18. doi: 10.1055/a-1827-8041.
   PubMed     Abstract available
   
   
   
9. GROSSE GM, Werlein C, Blume N, Abu-Fares O, et al
   Circulating Cytokines and Growth Factors in Acute Cerebral Large Vessel Occlusion-Association with Success of Endovascular Treatment.
   Thromb Haemost. 2022;122:623-632.
   PubMed     Abstract available
   
   
   March 2022
10. MALY M, Riedel T, Stikarova J, Suttnar J, et al
    Incorporation of Fibrin, Platelets, and Red Blood Cells into a Coronary Thrombus in Time and Space.
    Thromb Haemost. 2022;122:434-444.
    PubMed     Abstract available
    
    
    
11. KITANO T, Hori Y, Okazaki S, Shimada Y, et al
    An Older Thrombus Delays Reperfusion after Mechanical Thrombectomy for Ischemic Stroke.
    Thromb Haemost. 2022;122:415-426.
    PubMed     Abstract available
    
    
    January 2022
12. CHAO TF, Joung B, Takahashi Y, Lim TW, et al
    2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary.
    Thromb Haemost. 2022;122:20-47.
    PubMed     Abstract available
    
    
    November 2021
13. BLASCO A, Coronado MJ, Vela P, Martin P, et al
    Prognostic implications of Neutrophil Extracellular Traps in coronary thrombi of patients with ST-elevation myocardial infarction.
    Thromb Haemost. 2021 Nov 30. doi: 10.1055/a-1709-5271.
    PubMed     Abstract available
    
    
    October 2021
14. SCHUCHARDT FF, Demerath T, Elsheikh S, Wehrum T, et al
    Dural Arteriovenous Fistula Formation Secondary to Cerebral Venous Thrombosis: Longitudinal Magnetic Resonance Imaging Assessment Using 4D-Combo-MR-Venography.
    Thromb Haemost. 2021;121:1345-1352.
    PubMed     Abstract available
    
    
    September 2021
15. MONTALTO C, Crimi G, Morici N, Palmerini T, et al
    Validation and Additive Predictive Value of the Academic Research Consortium-High Bleeding Risk Criteria in Older Adults.
    Thromb Haemost. 2021;121:1255-1257.
    PubMed    
    
    
    May 2021
16. COLE O
    Atrial Fibrillation After Cardiac Surgery - To Infinity and Beyond!
    Thromb Haemost. 2021 May 11. doi: 10.1055/a-1506-8744.
    PubMed     Abstract available
    
    
    March 2021
17. FABRIS E, Korjian S, Coller B, Ten Berg JM, et al
    Pre-Hospital Antiplatelet Therapy for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention: What We Know and What Lies Ahead.
    Thromb Haemost. 2021 Mar 7. doi: 10.1055/a-1414-5009.
    PubMed     Abstract available
    
    
    January 2021
18. GUEDENEY P, Collet JP
    Antithrombotic Therapy in Acute Coronary Syndromes: Current Evidence and Ongoing Issues Regarding Early and Late Management.
    Thromb Haemost. 2021 Jan 27. doi: 10.1055/s-0040-1722188.
    PubMed     Abstract available
    
    
    
19. MANDROLA JM, Kaul S, Foy A
    Lessons Learnt from Recent Trials in Ischemic Heart Disease.
    Thromb Haemost. 2021;121:8-14.
    PubMed     Abstract available
    
    
    December 2020
20. AZNAOURIDIS K, Tselegkidi ME, Kanakakis I, Alexopoulos D, et al
    Dual Antithrombotic Therapy in Atrial Fibrillation Patients undergoing Percutaneous Coronary Angioplasty: The Impact of Bleeding Risk Score on Outcome.
    Thromb Haemost. 2020 Dec 30. doi: 10.1055/s-0040-1721777.
    PubMed    
    
    
    
21. LAINE M, Panagides V, Frere C, Cuisset T, et al
    On-ticagrelor platelet reactivity and clinical outcome in patients undergoing percutaneous coronary intervention for acute coronary syndrome.
    Thromb Haemost. 2020 Dec 1. doi: 10.1055/a-1326-5110.
    PubMed     Abstract available
    
    
    November 2020
22. MONTALTO C, Ferlini M, Casula M, Mandurino-Mirizzi A, et al
    DAPT Score to Stratify Ischemic and Bleeding Risk after Percutaneous Coronary Intervention: An Updated Systematic Review, Meta-Analysis, and Meta-Regression of 100,211 Patients.
    Thromb Haemost. 2020 Nov 19. doi: 10.1055/s-0040-1721145.
    PubMed    
    
    
    October 2020
23. ZHENG YY, Wu TT, Gao Y, Guo QQ, et al
    A Novel ABC Score Predicts Mortality in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Who underwent Percutaneous Coronary Intervention.
    Thromb Haemost. 2020 Oct 31. doi: 10.1055/s-0040-1718411.
    PubMed     Abstract available
    
    
    July 2020
24. FERNANDO H, McFadyen JD, Palasubramaniam J, Shaw J, et al
    Antithrombotic Therapy in Myocardial Infarction: Historic Perils and Current Challenges-A 70-Year Journey.
    Thromb Haemost. 2020 Jul 24. doi: 10.1055/s-0040-1714212.
    PubMed     Abstract available
    
    
    
25. LIU Z, Tian R, Wang Y, Chen Q, et al
    Platelet Inhibition with Ticagrelor versus Clopidogrel in Diabetic Patients after Percutaneous Coronary Intervention for Chronic Coronary Syndromes.
    Thromb Haemost. 2020 Jul 15. doi: 10.1055/s-0040-1713375.
    PubMed     Abstract available
    
    
    June 2020
26. KAZEM N, Sulzgruber P, Thaler B, Baumgartner J, et al
    CD8+CD28null T Lymphocytes are Associated with the Development of Atrial Fibrillation after Elective Cardiac Surgery.
    Thromb Haemost. 2020 Jun 28. doi: 10.1055/s-0040-1713096.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vascular Surgery is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: